
    
      There are two parts of phase IVd clinical trials have been performed. First, to evaluate the
      immunogenicity of the inactive EV71 vaccine within two measles attenuated live vaccine and
      live attenuated Japanese encephalitis vaccine at the same time point in large scale
      population of Chinese children (8 months old), within 56-day-post-immunized.

      Second, to safety of the inactive EV71 vaccine within two measles attenuated live vaccine and
      live attenuated Japanese encephalitis vaccine at the same time point in large scale
      population of Chinese children (8 months old), within 56-day-post-immunized.
    
  